IFF Eyes Billion-Dollar Pharma Unit Sale

By Patricia Miller


In this article

  • Loading...
  • Want to see what you should be buying? Check out our top picks.

IFF considers selling its pharma unit and Lucas Meyer cosmetics business. The sales could positively impact its debt profile and offer investment opportunities.

IFF Logo on a smartphone screen.
Industry Peers and Equity Firms Show Interest in IFF Unit

What You Need To Know 

  • International Flavors & Fragrances Inc. (NYSE: IFF) is considering selling its pharma solutions unit, which could be valued at over $3.5 billion.

  • Industry peers and private equity firms have shown interest in acquiring the unit.

  • IFF is also looking into selling its cosmetics business, Lucas Meyer, for more than $1 billion as part of a broader strategy to reduce debt.

  • The company's stock has dropped about 30% over the past year, partly due to antitrust investigations in multiple countries.

  • IFF maintains that it is cooperating with these antitrust investigations.

International Flavors & Fragrances Inc. (IFF) is contemplating the sale of its pharma solutions division. Sources familiar with the situation indicate that the unit could command a price tag exceeding $3.5 billion.

While IFF has not made a final decision, the unit has already piqued the interest of industry competitors and private equity firms. This potential sale is part of IFF's larger strategy to slim down its business portfolio and decrease its debt. In another move toward this goal, the company is also exploring the sale of its cosmetics business, Lucas Meyer, for over $1 billion.

In the stock market, IFF hasn't been performing well. Over the past year, the company's stock has taken a nearly 30% hit. This downturn is linked to ongoing investigations by antitrust authorities in multiple regions, including the US and Europe, into suspected price-fixing activities by IFF and its competitors. The company asserts that it is cooperating fully with these investigations.

Why This Is Important for Retail Investors 

  1. Asset Reallocation: If IFF successfully sells its pharma solutions unit and Lucas Meyer cosmetics business, it could significantly reduce its debt. For retail investors, this is a positive sign that the company is taking proactive steps to strengthen its balance sheet, potentially making IFF stock a more stable investment.

  2. Focus on Core Business: Selling off peripheral units allows IFF to concentrate on its core competencies. For investors, this focus could result in improved operational efficiency and potentially higher profits.

  3. Market Reaction: The company's stock has been underperforming, largely due to antitrust investigations. A successful sale could serve as a catalyst for stock price recovery. Retail investors may find this an opportune time for entry or to average down their investment cost.

  4. Investor Sentiment: The interest from industry peers and private equity firms in IFF's pharma solutions unit indicates its inherent value. This could boost investor confidence in the company's overall valuation, possibly driving the stock price up.

  5. Regulatory Risks: The ongoing antitrust investigations pose a risk that retail investors should not ignore. Any news on this front, positive or negative, will likely have a significant impact on the stock price. Keeping an eye on how IFF manages these challenges can inform investment decisions.

How Can You Use This Information?

Here are some of the investing ideas that can be explored using this information: 

Value Investing

  • With a near 30% drop in stock price over the past year, value investors might see this as a buying opportunity, especially if the sales of the pharma and cosmetics units go through and significantly reduce debt. The reduced price could be viewed as a temporary undervaluation, offering long-term value.

Growth Investing

  • If IFF successfully divests its non-core units and uses the proceeds to focus on its core businesses, this could be a catalyst for growth. Investors looking for companies with growth potential may consider this a good entry point, anticipating that the streamlined operations could lead to revenue growth.

Momentum Investing

  • If the sales generate significant capital or if the antitrust investigations conclude favorably for IFF, the stock may experience a rapid uptick. Momentum investors could capitalize on this by riding the wave of positive news to gain short-term profits.

Dividend Investing

  • If IFF manages to reduce its debt and strengthen its balance sheet, it might sustain or even increase dividend payouts. For those interested in income-generating investments, this could make IFF an attractive option.

Contrarian Investing

  • Given the ongoing antitrust investigations and stock underperformance, some investors might be shying away from IFF. Contrarian investors could view this as an opportunity to invest when sentiment is low, aiming to profit when the company eventually recovers.

Sector Rotation

  • If IFF sells off its pharma unit, investors might also look at how this reshapes the competitive landscape within the sector. Depending on the buyer, this could create new opportunities or threats for other companies in the space, which could be another investment angle to explore.

Read What Others Are Saying

What you should read next:

Investing with Insight

Knowing where to invest is not easy. Bullish and bearish sentiment is always vying for control, and investors like you can very quickly become overwhelmed.

And yet, no matter what the wider stock market is doing, there are always little-known gems to uncover. 

One potential growth stock flying under the radar is a dynamic company operating at the forefront of the entertainment industry. This business is diverse and multifaceted and led by industry veterans with extensive experience in entertainment and investment.

This high-potential US stock is targeting India’s tech-hungry 1.4 billion people.

Internet and social media adoption in India is surging, and the country has the LARGEST youth population worldwide. Over 650M people are under 25 years old, and 850M are under 35 years old. 

With rising economic and educational prospects, the country is a hotbed for digital engagement.

Some highlights you’ll want to know include:

  • This is one of the fastest-growing creator-media companies in India and the United States.

  • This company reaches 1 billion global consumers every month.

  • India was the second-fastest-growing market in the influencer marketing space in 2022. 

  • Global influencer marketing spend is expected to reach $34 billion in 2023.

  • This company has posted nine consecutive quarters of YoY growth, representing a 33% CAGR using its repeatable content strategy.

  • This impressive small-cap has just appointed a former TikTok Country manager as its India Group CEO. 

Finally, this stock is analyst-backed with a potential 114% upside from the analyst initiation date.

If you're intrigued by this stock’s promising prospects, why not take a closer look?


In this article:


Author: Patricia Miller

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.

Patricia Miller does not hold any position in the stock(s) and/or financial instrument(s) mentioned in the above article.

Patricia Miller has not been paid to produce this piece by the company or companies mentioned above.

Digitonic Ltd, the owner of ValueTheMarkets.com, does not hold a position or positions in the stock(s) and/or financial instrument(s) mentioned in the above article.

Digitonic Ltd, the owner of ValueTheMarkets.com, has not been paid for the production of this piece by the company or companies mentioned above.

Sign up for Investing Intel Newsletter